Guangdong Hybribio Biotech Co.,Ltd.
SZSE:300639.SZ
8.67 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| 68.514 | 1,801.402 | 884.937 | 394.657 | 136.956 | 106.743 | 91.763 | 74.564 | 64.416 | 63.459 | 29.17 | 19.725 |
Depreciation & Amortization
| 178.43 | 178.893 | 87.301 | 50.042 | 41.209 | 30.765 | 27.368 | 24.292 | 14.234 | 10.886 | 2.41 | 0.999 |
Deferred Income Tax
| -59.632 | -79.613 | 26.637 | 9.583 | -9.557 | 0.92 | -6.008 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| -3.641 | 6.166 | 7.006 | 0.789 | 2.421 | 5.25 | 4.41 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 63.533 | -1,363.964 | -382.668 | -163.125 | -76.263 | -68.156 | -51.112 | -42.164 | -35.095 | -43.225 | 0 | 0 |
Accounts Receivables
| 873.516 | -1,919.958 | -648.083 | -275.723 | -71.009 | -1.686 | -56.53 | -28.163 | 0 | 0 | 0 | 0 |
Inventory
| 52.377 | -63.36 | -51.154 | -53.208 | -3.617 | -9.795 | 2.207 | -5.5 | -5.664 | -8.727 | 0 | 0 |
Accounts Payables
| -802.728 | 698.967 | 289.932 | 156.224 | 7.921 | -57.595 | 9.219 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -59.632 | -79.613 | 26.637 | 9.583 | -9.557 | -58.361 | -53.319 | -36.664 | -29.431 | -34.498 | 0 | 0 |
Other Non Cash Items
| 80.03 | 762.429 | 8.129 | 19.354 | 18.066 | 11.037 | 11.146 | 6.939 | 4.914 | 3.531 | -29.17 | -19.725 |
Operating Cash Flow
| 327.234 | 1,309.216 | 631.342 | 311.3 | 112.832 | 80.39 | 79.165 | 63.631 | 48.469 | 34.652 | 22.891 | 16.084 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -385.321 | -734.366 | -641.072 | -287.116 | -196.562 | -144.43 | -66.992 | -77.294 | -129.889 | -79.722 | -26.681 | -29.747 |
Acquisitions Net
| 0 | 13.725 | 2.838 | 294.04 | 200.211 | -0 | 67.124 | 12 | 2.573 | 0.998 | 0 | 29.747 |
Purchases Of Investments
| -1,017.178 | -2,541.864 | -2,643.2 | -2,154.4 | -405 | -1,132.93 | -878.904 | 0 | 0 | 0 | 0 | -65.4 |
Sales Maturities Of Investments
| 1,091.909 | 2,657.758 | 2,774.586 | 1,244.727 | 729.794 | 1,076.367 | 611.937 | 0 | 0 | 0 | 12.108 | 73.669 |
Other Investing Activites
| 17.741 | 0 | 3.5 | -287.116 | -196.562 | 0.495 | -66.992 | 0 | 0.073 | 0.001 | 0.003 | -29.747 |
Investing Cash Flow
| -292.85 | -604.747 | -503.348 | -1,189.865 | 131.882 | -200.497 | -333.827 | -77.294 | -129.816 | -78.723 | -14.57 | -21.478 |
Financing Activities: | ||||||||||||
Debt Repayment
| -68.025 | -52.944 | 76.059 | 75.272 | 0 | 0 | -10 | 10 | 0 | -39.714 | 39.894 | -5 |
Common Stock Issued
| 0 | 49.999 | 49.974 | 50.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -49.999 | -49.999 | -49.974 | -50.18 | -0.412 | -80.151 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -150.9 | -101.936 | -69.825 | -42.463 | -44.252 | -45.509 | -0.019 | -0.42 | 0 | -1.028 | -1.325 | -0.137 |
Other Financing Activities
| -25.477 | -2.179 | 12.026 | 1,033.926 | 0.528 | 38.55 | 398.158 | 10.422 | 18.324 | 92.89 | 29.478 | 0.45 |
Financing Cash Flow
| -294.4 | -219.409 | 8.498 | 1,016.555 | -43.724 | -6.959 | 388.158 | 20.001 | 18.324 | 52.148 | 68.047 | -4.687 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0.948 | 13.403 | -5.478 | -4.365 | 0.763 | -1.718 | -0.546 | 0.311 | 0.233 | -0.031 | -0.466 | 0.319 |
Net Change In Cash
| -259.068 | 498.463 | 131.014 | 133.626 | 201.753 | -128.783 | 132.95 | 6.649 | -62.79 | 8.045 | 75.901 | -9.762 |
Cash At End Of Period
| 761.368 | 1,020.436 | 521.973 | 390.958 | 257.333 | 55.58 | 184.363 | 51.413 | 44.763 | 107.553 | 99.508 | 23.607 |